Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/rth2.12485 http://scihub22266oqcxt.onion/10.1002/rth2.12485 33733027!7938613!33733027     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33733027&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Res+Pract+Thromb+Haemost 2021 ; 5 (2): 292-295 Nephropedia Template TP {{tp|p=33733027|t=2021. Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors |pdf=|usr=}}{{33733027}} gab.com Text Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors JO: Res Pract Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33733027 #FOAvip BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with high rates of thromboembolic events in hospitalized patients. It remains to be determined if this risk persists following hospital discharge. METHODS: We conducted a retrospective cohort study of outpatients recently hospitalized for COVID-19 to determine the incidence of vascular thromboembolic events within 30 days of discharge. We investigated the risk factors associated with these events, including intensive care admission, age, and anticoagulation. RESULTS: Among 447 patients hospitalized for COVID-19, 2.0% experienced a vascular thromboembolic event within 30 days of discharge. No risk factor variable was significantly associated with an increased risk for these events. CONCLUSIONS: The incidence of vascular thromboembolic events following hospital discharge for COVID-19 is low. These findings suggest against the routine use of postdischarge thromboprophylaxis in patients with COVID-19. Twit Text FOAVip Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors ????Res Pract Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33733027 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33733027 #FOAvip English Wikipedia <ref>{{Cite pmid|33733027}}</ref> Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors #MMPMID33733027 Eswaran H; Jarmul JA; Shaheen AW; Meaux D; Long T; Saccoccio D; Moll S Res Pract Thromb Haemost 2021[Feb]; 5 (2): 292-295 PMID33733027show ga BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with high rates of thromboembolic events in hospitalized patients. It remains to be determined if this risk persists following hospital discharge. METHODS: We conducted a retrospective cohort study of outpatients recently hospitalized for COVID-19 to determine the incidence of vascular thromboembolic events within 30 days of discharge. We investigated the risk factors associated with these events, including intensive care admission, age, and anticoagulation. RESULTS: Among 447 patients hospitalized for COVID-19, 2.0% experienced a vascular thromboembolic event within 30 days of discharge. No risk factor variable was significantly associated with an increased risk for these events. CONCLUSIONS: The incidence of vascular thromboembolic events following hospital discharge for COVID-19 is low. These findings suggest against the routine use of postdischarge thromboprophylaxis in patients with COVID-19. ?Vascular thromboembolic events following COVID-19 hospital discharge: (epmc).pdf DeepDyve Pubget Overpricing